Default company panoramic image

Inspiro Medical

Inspiro Medical developments Inspiromatic™, a novel dry powder inhaler for the treatment of pulmonary diseases, multi-billion dollar market

  • Stage Full Product Ready
  • Industry Biotechnology
  • Location Ilanot, Karmiel, Israel
  • Currency USD
  • Founded December 2010
  • Employees 3
  • Website

Company Summary

Medical device company developing Inspiromatic™, a novel dry powder inhaler for the treatment of pulmonary diseases. The company successfully completed FIM trial in asthma patients. Inspiromatic™ enables improved lung drug deposition, monitor patient inhalation and real-time feedback interface. Inspiro is seeking an investment, to enhance its product development and engage global pharma companies in the development of drug-device formulation.


  • Default avatar
    Nimrod Kaufmann

    15 years of experience in the medical device industry, taking products from initial concept to final product.
    Developed various medical devices in the field of orthopedics and cardiovascular including ConfidenceTM cement system- Disc-O-Tech Ltd (acquired by Kyphon for $220m)
    Anastomotic device- By-Pass Maakafim.
    Endovascular stent system- Existent Ltd.
    Holds B.Sc. in Mechanical Engineering from Ben-Gurion University.

  • Default avatar
    Guy Steuer
    Medical Director

    Senior physician and pediatric pulmonologist at Schneider Children Medical Center, Israel.
    Holds an M.D. from the Hebrew University of Jerusalem, as well as a pulmonology fellowship from the University of Pittsburgh.

  • Default avatar
    Nir Gamliel
    VP Business Development

    CEO of PharBeyond a business development consulting firm.
    Held senior management positions in Fortune 500 companies and start-ups.
    He has led partnering campaigns for drugs and medical devices.
    Served as VP BD at BioLineRx, (BLRX), VP Sales and Marketing at BSP, Inc. VP Sales at Compugen USA, Inc. (NASDAQ:CGEN), Sales and Marketing Manager at Voltaire Ltd. (VOLT), and a Franchise Manager at J&J.
    Holds a B.Sc. in Biology, Bar Ilan Universit

Previous Investors

  • Default avatar
    Trendlines Group
    Default avatar
    Israel OCS